Project Grant R01AG093763

Award Date 6/1/25
Completion Date 3/31/30
Dollars Obligated $1M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $466,125 to New York University (NYU) to develop a biologically relevant multi-scale model of brain aging using advanced diffusion MRI (dMRI) techniques. The project aims to generate brain charts of quantitative dMRI and mesoscopic MRI (mesoMRI) markers across the lifespan, creating a brain microstructure age framework. This framework will then be used to evaluate the effects of...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $416,480 to the University of Washington to map the landscape of the aged human brain and develop neurodegenerative disease models. The award will fund a two-phase research project that aims to: 1) identify molecular drivers of brain aging by applying explainable artificial intelligence (XAI) methods to human brain datasets, and 2) manipulate these aging drivers in human induced pluripotent stem...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $636,342 to Trustees of Boston University's Boston University Medical Campus to conduct multiscale modeling and empirical studies of normal and pathological brain aging. The research aims to elucidate the relationships between myelin dystrophy, synaptic loss, and neuronal hyperexcitability in the dorsolateral prefrontal cortex, and how these changes contribute to age- and Alzheimer's...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to establish the feasibility and reproducibility of using hyperpolarized 13C pyruvate magnetic resonance imaging (MRI) to study glucose metabolism in the human brain. The $427,625 award, effective September 15, 2024, will fund two key objectives: 1) in vitro testing using a 3D-printed phantom to evaluate the imaging approach, and 2) in vivo evaluation of the reproducibility of...
This $427,625 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to elucidate the mechanisms by which microgliopathy, a genetic neurological disorder, causes early-onset dementia. The research will investigate how the loss of the DAP12 protein in microglia, the immune cells of the brain, leads to heightened signaling of the RUNX and STAT3 pathways. This dysregulation is hypothesized to disrupt normal microglial functions and induce brain pathology and...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the Trustees of Boston University, doing business as Boston University Medical Campus, provides $2,330,859.00 in funding to study age-related changes in brain network connectivity and their relationship to cognitive decline. The 3-year project aims to use multimodal neuroimaging, single-cell transcriptomics, electrophysiology, and neural tract-tracing in a rhesus monkey model to delineate how...
This $4.46 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866) to develop a new in vivo magnetic resonance imaging biomarker for early detection of Alzheimer's disease neurodegeneration. Specifically, the awardee, Washington University, will utilize quantitative gradient recalled echo MRI techniques to identify two types of hippocampal tissue in preclinical and mild...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to identify the molecular mechanisms underlying the conversion of glial cells into functional new neurons in the aged adult brain. The $126,956 award, effective April 1, 2025 through February 28, 2027, will enable the University of California, San Diego to utilize single-cell spatial transcriptomics technology to systematically map the cellular pathways and molecular events involved...
The National Institutes of Health National Institute on Aging awarded $4,575,712 under the Aging Research program (CFDA 93.866) to The Washington University from May 2022 to April 2025. The award will support research into white matter metabolism in the context of aging, white matter hyperintensities, and Alzheimer's disease. Investigators will apply quantitative positron emission tomography imaging techniques to measure cerebral oxygen consumption, blood flow, oxygen extraction fraction, and...
This Project Grant award from the National Institute on Aging (NIA, CFDA 93.866 Aging Research) will develop three new multi-modal atlases based on data from the Human Connectome Project (HCP). The $1,554,682 award, which runs from December 15, 2024 to November 30, 2029, will: Create a new data-driven atlas of spatially overlapping weighted grey-matter functional networks. Develop a new data-driven atlas of white matter tracts and their corresponding grey matter projection territories....

This Project Grant award of $1,005,081 from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to determine the degree to which understanding of healthy and pathological brain aging can be informed by early neurodevelopment. The key goals are to: 1) Quantify similarities and differences in the spatiotemporal progression of brain development and degeneration, 2) Determine the impact of deprivation and genetic risk on functional and structural brain development and degeneration, and 3) Elucidate early-life contributions to accelerated brain aging and susceptibility to degenerative diseases. The research will leverage multiple longitudinal datasets with advanced neuroimaging, clinical/cognitive phenotyping, and genotyping. The award recipient is The Washington University, a private research institution located in University City, Missouri.

Generated 8/5/25, 5:21 AM